Skip to main content

Advertisement

SpringerLink
Log in

Inspiratory Muscle Training in Late-Onset Pompe Disease: The Effects on Pulmonary Function Tests, Quality of Life, and Sleep Quality

  • Published:
Lung Aims and scope Submit manuscript

Abstract

Introduction

Late-onset Pompe disease (LOPD) is characterized by progressive skeletal and respiratory muscle weakness. Little is known about the effect of inspiratory muscle training (IMT) on pulmonary function in subjects with LOPD. The aim of the present study was to investigate the effect of an 8-week IMT program on pulmonary function tests, quality of life, and sleep quality in eight patients with LOPD who were receiving enzyme replacement therapy (ERT).

Methods

Before and after the IMT program, spirometric measurements in sitting and supine positions, and measurements of maximum inspiratory and expiratory pressures, peak cough flow, quality of life (assessed using the Nottingham Health Profile), and sleep quality (assessed using the Pittsburgh sleep quality index) were performed.

Results

A significant increase in maximum inspiratory pressure (cmH2O and % predicted) (median [interquartile range]: 30.0 cmH2O [21.5–48] versus 39 cmH2O [31.2–56.5] and 38.3 % [28.1–48.4] versus 50.5 % [37.7–54.9]) was observed after training (p = 0.01). There were no significant changes in the other pulmonary function measurements. With the exception of the social isolation subscore (p = 0.02), quality of life subscores did not change after IMT (p > 0.05). Sleep quality subscores and total scores were similar before and after IMT.

Conclusion

These results suggest that IMT has a positive effect on maximum inspiratory pressure in subjects with LOPD who are under ERT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bembi B, Cerini E, Danesino C et al (2008) Diagnosis of glycogenosis type II. Neurology 71(23 Suppl 2):S4–S11. doi:10.1212/WNL.0b013e31818da91e

    Article  CAS  PubMed  Google Scholar 

  2. Kishnani PS, Steiner RD, Bali D et al (2006) Pompe disease diagnosis and management guideline. Genet Med 8(5):267–288. doi:10.1097/01.gim.0000218152.87434.f3

    Article  PubMed  PubMed Central  Google Scholar 

  3. van der Ploeg AT, Reuser AJ (2008) Pompe’s disease. Lancet (Lond) 372(9646):1342–1353. doi:10.1016/s0140-6736(08)61555-x

    Article  Google Scholar 

  4. Gungor D, Reuser AJ (2013) How to describe the clinical spectrum in Pompe disease? Am J Med Genet A 161(2):399–400. doi:10.1002/ajmg.a.35662

    Article  Google Scholar 

  5. Kishnani PS, Howell RR (2004) Pompe disease in infants and children. J Pediatr 144(5 Suppl):S35–S43. doi:10.1016/j.jpeds.2004.01.053

    Article  CAS  PubMed  Google Scholar 

  6. Vianello A, Semplicini C, Paladini L et al (2013) Enzyme replacement therapy improves respiratory outcomes in patients with late-onset type II glycogenosis and high ventilator dependency. Lung 191(5):537–544. doi:10.1007/s00408-013-9489-x

    Article  CAS  PubMed  Google Scholar 

  7. Hagemans ML, Winkel LP, Van Doorn PA et al (2005) Clinical manifestation and natural course of late-onset Pompe’s disease in 54 Dutch patients. Brain 128(3):671–677. doi:10.1093/brain/awh384

    Article  CAS  PubMed  Google Scholar 

  8. Hagemans ML, Winkel LP, Hop WC et al (2005) Disease severity in children and adults with Pompe disease related to age and disease duration. Neurology 64(12):2139–2141. doi:10.1212/01.wnl.0000165979.46537.56

    Article  CAS  PubMed  Google Scholar 

  9. Winkel LP, Hagemans ML, van Doorn PA et al (2005) The natural course of non-classic Pompe’s disease; a review of 225 published cases. J Neurol 252(8):875–884. doi:10.1007/s00415-005-0922-9

    Article  PubMed  Google Scholar 

  10. Mellies U, Stehling F, Dohna-Schwake C et al (2005) Respiratory failure in Pompe disease: treatment with noninvasive ventilation. Neurology 64(8):1465–1467. doi:10.1212/01.wnl.0000158682.85052.c0

    Article  CAS  PubMed  Google Scholar 

  11. Mellies U, Ragette R, Schwake C et al (2001) Sleep-disordered breathing and respiratory failure in acid maltase deficiency. Neurology 57(7):1290–1295

    Article  CAS  PubMed  Google Scholar 

  12. Margolis ML, Howlett P, Goldberg R et al (1994) Obstructive sleep apnea syndrome in acid maltase deficiency. Chest 105(3):947–949

    Article  CAS  PubMed  Google Scholar 

  13. Katzin LW, Amato AA (2008) Pompe disease: a review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy. J Clin Neuromuscul Dis 9(4):421–431. doi:10.1097/CND.0b013e318176dbe4

    Article  PubMed  Google Scholar 

  14. Mellies U, Lofaso F (2009) Pompe disease: a neuromuscular disease with respiratory muscle involvement. Respir Med 103(4):477–484. doi:10.1016/j.rmed.2008.12.009

    Article  PubMed  Google Scholar 

  15. Hagemans ML, Janssens AC, Winkel LP et al (2004) Late-onset Pompe disease primarily affects quality of life in physical health domains. Neurology 63(9):1688–1692

    Article  CAS  PubMed  Google Scholar 

  16. Ambrosino N, Confalonieri M, Crescimanno G et al (2013) The role of respiratory management of Pompe disease. Respir Med 107(8):1124–1132. doi:10.1016/j.rmed.2013.03.004

    Article  PubMed  Google Scholar 

  17. Nici L, Donner C, Wouters E et al (2006) American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 173(12):1390–1413. doi:10.1164/rccm.200508-1211ST

    Article  PubMed  Google Scholar 

  18. Jones HN, Moss T, Edwards L et al (2011) Increased inspiratory and expiratory muscle strength following respiratory muscle strength training (RMST) in two patients with late-onset Pompe disease. Mol Genet Metab 104(3):417–420. doi:10.1016/j.ymgme.2011.05.006

    Article  CAS  PubMed  Google Scholar 

  19. Jones HN, Crisp KD, Robey RR et al (2016) Respiratory muscle training (RMT) in late-onset Pompe disease (LOPD): effects of training and detraining. Mol Genet Metab 117(2):120–128. doi:10.1016/j.ymgme.2015.09.003

    Article  CAS  PubMed  Google Scholar 

  20. Holden MK, Gill KM, Magliozzi MR et al (1984) Clinical gait assessment in the neurologically impaired. Reliability and meaningfulness. Phys Ther 64(1):35–40

    CAS  PubMed  Google Scholar 

  21. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166(1):111–117. doi:10.1164/ajrccm.166.1.at1102

    Article  Google Scholar 

  22. Enright PL, Sherrill DL (1998) Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med 158(5 Pt 1):1384–1387. doi:10.1164/ajrccm.158.5.9710086

    Article  CAS  PubMed  Google Scholar 

  23. Miller MR, Hankinson J, Brusasco V et al (2005) Standardisation of spirometry. Eur Respir J 26(2):319–338. doi:10.1183/09031936.05.00034805

    Article  CAS  PubMed  Google Scholar 

  24. Quanjer PH, Tammeling GJ, Cotes JE et al (1993) Lung volumes and forced ventilatory flows. Eur Respir J 6(Suppl 16):5–40. doi:10.1183/09041950.005s1693

    Article  PubMed  Google Scholar 

  25. Allen SM, Hunt B, Green M (1985) Fall in vital capacity with posture. Br J Dis Chest 79(3):267–271

    Article  CAS  PubMed  Google Scholar 

  26. Fromageot C, Lofaso F, Annane D et al (2001) Supine fall in lung volumes in the assessment of diaphragmatic weakness in neuromuscular disorders. Arch Phys Med Rehabil 82(1):123–128. doi:10.1053/apmr.2001.18053

    Article  CAS  PubMed  Google Scholar 

  27. American Thoracic Society (2002) ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med 166(4):518–624. doi:10.1164/rccm.166.4.518

    Article  Google Scholar 

  28. Black LF, Hyatt RE (1969) Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis 99(5):696–702

    CAS  PubMed  Google Scholar 

  29. Bianchi C, Baiardi P (2008) Cough peak flows: standard values for children and adolescents. Am J Phys Med Rehabil 87(6):461–467. doi:10.1097/PHM.0b013e318174e4c7

    Article  PubMed  Google Scholar 

  30. Gauld LM, Boynton A (2005) Relationship between peak cough flow and spirometry in Duchenne muscular dystrophy. Pediatr Pulmonol 39(5):457–460. doi:10.1002/ppul.20151

    Article  PubMed  Google Scholar 

  31. Hunt SM, McKenna SP, McEwen J et al (1981) The Nottingham Health Profile: subjective health status and medical consultations. Soc Sci Med A 15(3 Pt 1):221–229

    CAS  PubMed  Google Scholar 

  32. Kucukdeveci AA, McKenna SP, Kutlay S et al (2000) The development and psychometric assessment of the Turkish version of the Nottingham Health Profile. Int J Rehabil Res 23(1):31–38

    Article  CAS  PubMed  Google Scholar 

  33. Buysse DJ, Reynolds CF, Monk TH et al (1989) The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 28(2):193–213

    Article  CAS  PubMed  Google Scholar 

  34. Agargun MYKH, Anlar O (1996) Pittsburgh Uyku Kalitesi İndeksinin geçerliliği ve güvenilirliği. Türk Psikiyatri Dergisi 7:107–115

    Google Scholar 

  35. Topin N, Matecki S, Le Bris S et al (2002) Dose-dependent effect of individualized respiratory muscle training in children with Duchenne muscular dystrophy. Neuromuscul Disord NMD 12(6):576–583

    Article  PubMed  Google Scholar 

  36. Koessler W, Wanke T, Winkler G et al (2001) 2 Years’ experience with inspiratory muscle training in patients with neuromuscular disorders. Chest 120(3):765–769

    Article  CAS  PubMed  Google Scholar 

  37. Yeldan I, Gurses HN, Yuksel H (2008) Comparison study of chest physiotherapy home training programmes on respiratory functions in patients with muscular dystrophy. Clin Rehabil 22(8):741–748. doi:10.1177/0269215508091203

    Article  PubMed  Google Scholar 

  38. Aslan GK, Gurses HN, Issever H et al (2013) Effects of respiratory muscle training on pulmonary functions in patients with slowly progressive neuromuscular disease: a randomized controlled trial. Clin Rehabil 28(6):573–581. doi:10.1177/0269215513512215

    Article  PubMed  Google Scholar 

  39. Wanke T, Toifl K, Merkle M et al (1994) Inspiratory muscle training in patients with Duchenne muscular dystrophy. Chest 105(2):475–482

    Article  CAS  PubMed  Google Scholar 

  40. Fregonezi GA, Resqueti VR, Guell R et al (2005) Effects of 8-week, interval-based inspiratory muscle training and breathing retraining in patients with generalized myasthenia gravis. Chest 128(3):1524–1530. doi:10.1378/chest.128.3.1524

    Article  PubMed  Google Scholar 

  41. Jones HN, Crisp KD, Moss T et al (2014) Effects of respiratory muscle training (RMT) in children with infantile-onset Pompe disease and respiratory muscle weakness. J Pediatr Rehabil Med 7(3):255–265. doi:10.3233/prm-140294

    PubMed  Google Scholar 

  42. Gosselink R (2004) Breathing techniques in patients with chronic obstructive pulmonary disease (COPD). Chron Respir Dis 1(3):163–172

    Article  CAS  PubMed  Google Scholar 

  43. Smith BK, Collins SW, Conlon TJ et al (2013) Phase I/II trial of adeno-associated virus-mediated alpha-glucosidase gene therapy to the diaphragm for chronic respiratory failure in Pompe disease: initial safety and ventilatory outcomes. Hum Gene Ther 24(6):630–640. doi:10.1089/hum.2012.250

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Boentert M, Karabul N, Wenninger S et al (2015) Sleep-related symptoms and sleep-disordered breathing in adult Pompe disease. Eur J Neurol 22 (2):369–376, e327. doi:10.1111/ene.12582

Download references

Author information

Authors and Affiliations

  1. Division of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Istanbul University, Demirkapi Cad. Karabal Sk, 34147, Bakırkoy, Istanbul, Turkey

    Goksen Kuran Aslan & Burcu Ersoz Huseyinsinoglu

  2. Neurology Department, Memorial Sisli Hospital, Istanbul, Turkey

    Piraye Oflazer

  3. Division of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Bezmialem Vakif University, Istanbul, Turkey

    Nilgun Gurses

  4. Department of Chest Disease, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey

    Esen Kiyan

Authors
  1. Goksen Kuran Aslan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Burcu Ersoz Huseyinsinoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Piraye Oflazer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nilgun Gurses
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Esen Kiyan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Goksen Kuran Aslan.

Ethics declarations

Conflict of Interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aslan, G.K., Huseyinsinoglu, B.E., Oflazer, P. et al. Inspiratory Muscle Training in Late-Onset Pompe Disease: The Effects on Pulmonary Function Tests, Quality of Life, and Sleep Quality. Lung 194, 555–561 (2016). https://doi.org/10.1007/s00408-016-9881-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-016-9881-4

Keywords

Search

Navigation